Sydney researchers have received more than $6.4M to develop personalised treatments for ovarian cancer, investigate the link between sleep apnoea and tumour growth and improve the speed, accuracy and thoroughness of cancer diagnosis and treatment decision-making.
NSW Minister for Health and Medical Research, Brad Hazzard, announced the Cancer Institute NSW grants this week, with Sydney researchers receiving the most grants out of any institution.
Six University of Sydney researchers, five of which are female, received Early Career Fellowships and renowned oncologist Professor Roger Reddel, Director of the Children's Medical Research Institute at Westmead, was the only researcher awarded a Translational Program Grant.
He received $3.75M for his work at the ACRF International Centre for the Proteome of Human Cancer (ProCan™), part of the Cancer Moonshot Initiative external from 47th Vice President of the United States, Joe Biden.
Deputy-Vice Chancellor (Research) Professor Duncan Ivison said the grants not only highlighted Sydney’s strength in cancer research, but the extraordinary talent of our early career researchers.
“Our researchers have received half of the Early Career Fellowships awarded in this round.
“This is an outstanding result and we are proud of our talented researchers and their passionate commitment to finding new, safer and more personalised treatments for leukaemia, lung and ovarian cancer.”
University of Sydney researchers have won over $800,000 in grants from Diabetes Australia to improve the understanding, detection and treatment of diabetes.
Dementia, cancer, stuttering and alcohol addiction among problems University of Sydney researchers will tackle under new NHMRC funding, worth more than $30 million.
A real-time bullsh*t detector, a unique pathogen discovery centre and a new way to combat untreatable blindness are among the 21 projects funded under a new Sydney funding scheme.